Clinical Study
Sexually Transmitted Infections in Women Participating in a Biomedical Intervention Trial in Durban: Prevalence, Coinfections, and Risk Factors
Table 1
Coinfection among sexually transmitted infections reported in this study.
| | | STI negative
(%) | STI positive
(%) | value |
| | | CT negative | CT positive | |
| | All | 1,992 | 244 | — | | NG positive | 40 (2.01) | 31 (12.70) | <0.001 | | TV positive | 167 (8.38) | 33 (13.52) | <0.001 | | Syphilis positive | 56 (2.8) | — | — |
| | | T. pallidum negative | T. pallidum positive | |
| | All | 2,180 | 56 | | | NG positive | 71 (3.26) | — | — | | TV positive | 189 (8.67) | 11 (19.67) | 0.004 |
| | | NG negative | NG positive | |
| | All | 2,165 | 71 | | | TV positive | 191 (8.8) | 9 (12.7) | 0.263 |
|
|
CT: Chlamydia trachomatis, TV: Trichomonas vaginalis, NG: Neisseria gonorrhoeae.
|
